Avidity Biosciences [RNA] vs BridgeBio Pharma [BBIO] Detailed Stock Comparison

Avidity Biosciences

NASDAQ

BridgeBio Pharma

NASDAQ

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Avidity Biosciences wins in 5 metrics, BridgeBio Pharma wins in 12 metrics, with 0 ties. BridgeBio Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Avidity Biosciences	BridgeBio Pharma	Better
P/E Ratio (TTM)	-15.34	-16.98	BridgeBio Pharma
Price-to-Book Ratio	4.50	-5.24	BridgeBio Pharma
Debt-to-Equity Ratio	0.43	-1.04	BridgeBio Pharma
PEG Ratio	-0.18	-0.12	Avidity Biosciences
EV/EBITDA	-8.76	-17.51	BridgeBio Pharma
Profit Margin (TTM)	0.00%	98.25%	BridgeBio Pharma
Operating Margin (TTM)	-4,448.71%	-120.72%	BridgeBio Pharma
Return on Equity	-37.76%	36.76%	BridgeBio Pharma
Return on Assets (TTM)	-24.01%	-41.96%	Avidity Biosciences
Free Cash Flow (TTM)	$-307.94M	$-529.63M	Avidity Biosciences
1-Year Return	2.62%	98.46%	BridgeBio Pharma
Price-to-Sales Ratio (TTM)	533.37	39.80	BridgeBio Pharma
Enterprise Value	$4.54B	$10.92B	BridgeBio Pharma
EV/Revenue Ratio	423.57	46.32	BridgeBio Pharma
Gross Profit Margin (TTM)	N/A	96.70%	N/A
Revenue per Share (TTM)	$0	$1	BridgeBio Pharma
Earnings per Share (Diluted)	$-3.56	$-4.13	Avidity Biosciences
Beta (Stock Volatility)	0.95	1.23	Avidity Biosciences

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Avidity Biosciences vs BridgeBio Pharma Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Avidity Biosciences	3.82%	-3.06%	31.28%	45.85%	43.51%	43.23%
BridgeBio Pharma	-2.29%	-1.86%	9.43%	52.95%	36.31%	78.12%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Avidity Biosciences	2.62%	103.56%	56.59%	56.70%	56.70%	56.70%
BridgeBio Pharma	98.46%	379.29%	69.75%	86.24%	86.24%	86.24%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Avidity Biosciences (RNA): View Full Stock Overview

BridgeBio Pharma (BBIO): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Avidity Biosciences vs BridgeBio Pharma

Metric	RNA	BBIO
Market Information
Market Cap i	$5.72B	$9.39B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	4,696,850	3,620,747
90 Day Avg. Volume i	3,567,293	2,736,729
Last Close	$46.37	$49.08
52 Week Range	$21.51 - $56.00	$21.72 - $51.86
% from 52W High	-17.21%	-5.36%
All-Time High	$56.00 (Nov 11, 2024)	$73.50 (Feb 08, 2021)
% from All-Time High	-17.20%	-33.22%
Growth Metrics
Quarterly Revenue Growth	0.88%	50.00%
Quarterly Earnings Growth	0.88%	50.00%
Financial Health
Profit Margin (TTM) i	0.00%	0.98%
Operating Margin (TTM) i	-44.49%	-1.21%
Return on Equity (TTM) i	-0.38%	0.37%
Debt to Equity (MRQ) i	0.43	-1.04
Cash & Liquidity
Book Value per Share (MRQ)	$9.88	$-9.35
Cash per Share (MRQ)	$9.20	$3.96
Operating Cash Flow (TTM) i	$-489,980,992	$-655,808,000
Levered Free Cash Flow (TTM) i	$-259,114,752	$-297,633,248
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Avidity Biosciences vs BridgeBio Pharma

Metric	RNA	BBIO
Price Ratios
P/E Ratio (TTM) i	-15.34	-16.98
Forward P/E i	-14.68	-16.04
PEG Ratio i	-0.18	-0.12
Price to Sales (TTM) i	533.37	39.80
Price to Book (MRQ) i	4.50	-5.24
Market Capitalization
Market Capitalization i	$5.72B	$9.39B
Enterprise Value i	$4.54B	$10.92B
Enterprise Value Metrics
Enterprise to Revenue i	423.57	46.32
Enterprise to EBITDA i	-8.76	-17.51
Risk & Other Metrics
Beta i	0.95	1.23
Book Value per Share (MRQ) i	$9.88	$-9.35

Financial Statements Comparison: Avidity Biosciences vs BridgeBio Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	RNA	BBIO
Revenue/Sales i	$3.85M	$116.63M
Cost of Goods Sold i	N/A	$2.64M
Gross Profit i	N/A	$113.99M
Research & Development i	$138.13M	$111.43M
Operating Income (EBIT) i	$-171.14M	$-103.80M
EBITDA i	$-170.33M	$-104.46M
Pre-Tax Income i	$-157.32M	$-169.61M
Income Tax i	N/A	N/A
Net Income (Profit) i	$-157.32M	$-169.61M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	RNA	BBIO
Cash & Equivalents i	$254.20M	$540.60M
Total Current Assets i	$1.43B	$695.17M
Total Current Liabilities i	$84.87M	$152.11M
Long-Term Debt i	$2.09M	$1.85B
Total Shareholders Equity i	$1.33B	$-1.64B
Retained Earnings i	$-1.01B	$-3.26B
Property, Plant & Equipment i	$19.63M	$13.86M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	RNA	BBIO
Operating Cash Flow i	$-114.30M	$-215.45M
Capital Expenditures i	$-3.75M	$0
Free Cash Flow i	$-128.58M	$-200.83M
Debt Repayment i	N/A	$-459.00M
Common Stock Repurchase i	N/A	$-50.05M

Short Interest & Institutional Ownership Analysis

Metric	RNA	BBIO
Shares Short i	16.21M	18.52M
Short Ratio i	6.27	7.46
Short % of Float i	0.13%	0.16%
Average Daily Volume (10 Day) i	4,696,850	3,620,747
Average Daily Volume (90 Day) i	3,567,293	2,736,729
Shares Outstanding i	119.89M	190.04M
Float Shares i	98.07M	151.20M
% Held by Insiders i	0.05%	0.05%
% Held by Institutions i	1.08%	1.02%

Dividend Analysis & Yield Comparison: Avidity Biosciences vs BridgeBio Pharma

Metric	RNA	BBIO
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Avidity Biosciences [RNA] vs BridgeBio Pharma [BBIO] Detailed Stock Comparison